CME/CE Podcast: Treating Iron Deficiency Anemia – What You Need to Know Now!
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/treating-iron-deficiency-anemia-what-you-need-to-know-nowFeaturing speakers Lee P. Shulman, MD, and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, moderated by Gregg Sherman, MD.Summary As prevalent as IDA is in the population, how do you treat their anemia and replete iron stores? Sulfate, gluconate, or maltol? This discussion, between two respective experts in primary care and OB/GYN and our primary care moderator, continues and concludes our 2-part podcast series to answer that question. Oral and parenteral iron repletion, managing and mitigating side effects, and monitoring efficacy of treatment round out the discussion on the management of IDA. This podcast was recorded and is being used with the permission of the presenters. Learning Objective Upon completion of this activity, learners should be able to: Utilize an evidence-based, patient approach to management of iron deficiency that maximizes adherence to treatment Accurately assess iron stores in patients with anemia and those on iron replacement therapy. This activity is accredited for CME/CE Credit.The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).Summary of Individual Disclosures Angela Golden has disclosed the following financial relationships: Consultant: Novo Nordisk Advisor: Gelesis Biotechnology, Currax Pharmaceuticals, Novo Nordisk, Alfasigma, Acella Pharmaceuticals, Scynexis, Hisamitsu Pharmaceutical Speaker: Novo Nordisk, Acella Pharmaceuticals Receipt of Royalty: Springer Lee Shulman has disclosed the following financial relationships: Consultant: Shield, Daiichi-Sankyo, Organon & Co., Mayne Pharma, Agile, China Pharma Holdings, Inc., Embryome, Biogix, Inc. Advisor: Shield, Organon & Co., Agile, China Pharma Holdings, Inc., Embryome, Biogix, Inc. Speaker: Shield, Daiichi-Sankyo, Mayne Pharm, Agile Member of Review Panel: Astellas Pharm Wendy Wright has disclosed the following financial relationships: Consultant: Moderna, Seqirus, Pfizer, Merck, Sanofi, GlaxoSmithKline, Bayer, Idorsia, Shield Therapeutics Speaker: AbbVie, Biohaven, Merck, Pfizer, and Sanofi This activity is supported by an educational grant from Shield Therapeutics. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.